The Effects of Mixed Grain on Blood Glucose and Insulin in Healthy Male
Primary Purpose
Healthy People, Diabetes Mellitus, Type 2
Status
Completed
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Mixed grain 1
Mixed grain 2
White rice
Glucose solution
Sponsored by

About this trial
This is an interventional treatment trial for Healthy People focused on measuring Mixed grains, Glycemic index, Giant embryonic brown rice, Giant embryonic rice, diabetes
Eligibility Criteria
Inclusion Criteria:
- Males, 19~60years old
- Bodyweight was more than 50 kg with ideal body weight within ±30%
- Less than 100 mg/dl in fasting blood glucose and less than 140 mg/dl in an oral glucose tolerance test (OGTT)
- Able to give informed consent
Exclusion Criteria:
- Major medical illness such as cardiovascular, neurologic, psychiatric, renal, pulmonary and hepatic diseases
- History of disease that could interfere with the test products or impede their absorption such as gastrointestinal disease or gastrointestinal surgery
- Medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
- Poor vital sign (systolic blood pressure: below 100 mmHg or above 150 mmHg, diastolic blood pressure: below 65 mmHg or above95 mmHg)
- Allergic or hypersensitive to any of the ingredients in the test products; treated with any drug within past 2 weeks
- Participation in any other clinical trials within past 2 months
- Alcohol consumption above 21 units per week or abnormal screening laboratory test
- Being judged by the responsible physician of the local study center as unfit to participate in the study
Sites / Locations
- Clinical Trial Center for Functional Foods; Chonbuk National University Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Experimental
Experimental
Active Comparator
Active Comparator
Arm Label
Giant embryonic brown rice
Giant embryonic rice
White rice
Glucose solution
Arm Description
Outcomes
Primary Outcome Measures
1. Glycemic index(GI) 2. Glucose, insulin AUC(incremental area under the curve) 3. C-peptide
Glycemic index (GI) was defined as the area under the glucose response curve after consumption of a test food divided by the area under the curve after consumption of a control food containing the same amount of carbohydrate and calculated using 50 g glucose as the reference. Plasma glucose will be measured at baseline, 15, 30, 45, 60, 90, and 120 minutes post ingestion of each test solution.
GI= (incremental blood glucose area of test meal/incremental area of glucose) × 100
Plasma glucose and insulin will be measured at baseline, 15, 30, 45, 60, 90, 120, 180 and 240 minutes post ingestion of each test solution, and area under the curve will be calculated.
Plasma c-peptide will be measured at baseline, 120 minutes post ingestion of each test solution.
Secondary Outcome Measures
Homeostatic model assessment-insulin resistance(HOMA-IR), quantitative insulin sensitivity check index(QUICKI), Insulinogenic index(IGI)
HOMA-IR={fasting insulin(µU/㎖) x fasting glucose(m㏖/L)}/22.5
QUICKI=1/log(insulin 0min)-log(glucose 0min)
IGI=(insulin 30min-fasting insulin)/(glucose 30min-fasting glucose)
Full Information
NCT ID
NCT01840982
First Posted
April 5, 2013
Last Updated
August 5, 2019
Sponsor
Chonbuk National University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT01840982
Brief Title
The Effects of Mixed Grain on Blood Glucose and Insulin in Healthy Male
Official Title
A Randomized, Crossover Clinical Trial, The Effects of Mixed Grain on Blood Glucose and Insulin in Healthy Male
Study Type
Interventional
2. Study Status
Record Verification Date
August 2019
Overall Recruitment Status
Completed
Study Start Date
October 2010 (undefined)
Primary Completion Date
November 2010 (Actual)
Study Completion Date
March 25, 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Chonbuk National University Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This study was an open, 4-treatment, 5-sequence, 5-day cross-over randomized design clinical trial to evaluate the efficacy of mixed grain on blood glucose, insulin and Glycemic index(GI) in healthy males.
Detailed Description
After a 12-hour fast, oral glucose or meal tolerance test was performed with blood samples drawn at time 0, 15, 30, 45, 90, 120, 150, and 180 min.
Serum levels of glucose, insulin, and C-peptide were analyzed by biochemical autoanalyzer. The area under the curve (AUC) changes in blood glucose were computed by the trapezoidal method.
Glycemic index(GI): the area under the glucose response curve after consumption of a test food divided by the area under the curve after consumption of a control food containing the same amount of carbohydrate and calculated using 50 g glucose as the reference.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Healthy People, Diabetes Mellitus, Type 2
Keywords
Mixed grains, Glycemic index, Giant embryonic brown rice, Giant embryonic rice, diabetes
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Giant embryonic brown rice
Arm Type
Experimental
Arm Title
Giant embryonic rice
Arm Type
Experimental
Arm Title
White rice
Arm Type
Active Comparator
Arm Title
Glucose solution
Arm Type
Active Comparator
Intervention Type
Dietary Supplement
Intervention Name(s)
Mixed grain 1
Other Intervention Name(s)
Mixed grain 1 (Giant embryonic brown rice) diet
Intervention Description
All test foods contained 50 g available carbohydrate from the test food products. A glass of 200 ml water was served together with the clinical trial food, and the participants were instructed to ingest the breakfast with 15 min.
Intervention Type
Dietary Supplement
Intervention Name(s)
Mixed grain 2
Other Intervention Name(s)
Mixed grain 2 (Giant embryonic rice) diet
Intervention Description
All test foods contained 50 g available carbohydrate from the test food products. A glass of 200 ml water was served together with the clinical trial food, and the participants were instructed to ingest the breakfast with 15 min.
Intervention Type
Dietary Supplement
Intervention Name(s)
White rice
Other Intervention Name(s)
control diet
Intervention Description
All test foods contained 50 g available carbohydrate from the test food products. A glass of 200 ml water was served together with the clinical trial food, and the participants were instructed to ingest the breakfast with 15 min.
Intervention Type
Other
Intervention Name(s)
Glucose solution
Other Intervention Name(s)
Reference diet
Intervention Description
All test foods contained 50 g available carbohydrate from the test food products.
Primary Outcome Measure Information:
Title
1. Glycemic index(GI) 2. Glucose, insulin AUC(incremental area under the curve) 3. C-peptide
Description
Glycemic index (GI) was defined as the area under the glucose response curve after consumption of a test food divided by the area under the curve after consumption of a control food containing the same amount of carbohydrate and calculated using 50 g glucose as the reference. Plasma glucose will be measured at baseline, 15, 30, 45, 60, 90, and 120 minutes post ingestion of each test solution.
GI= (incremental blood glucose area of test meal/incremental area of glucose) × 100
Plasma glucose and insulin will be measured at baseline, 15, 30, 45, 60, 90, 120, 180 and 240 minutes post ingestion of each test solution, and area under the curve will be calculated.
Plasma c-peptide will be measured at baseline, 120 minutes post ingestion of each test solution.
Time Frame
2 hour postprandial blood glucose, insulin, c-peptide
Secondary Outcome Measure Information:
Title
Homeostatic model assessment-insulin resistance(HOMA-IR), quantitative insulin sensitivity check index(QUICKI), Insulinogenic index(IGI)
Description
HOMA-IR={fasting insulin(µU/㎖) x fasting glucose(m㏖/L)}/22.5
QUICKI=1/log(insulin 0min)-log(glucose 0min)
IGI=(insulin 30min-fasting insulin)/(glucose 30min-fasting glucose)
Time Frame
fasting and postprandial (different times for 30min)
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
19 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Males, 19~60years old
Bodyweight was more than 50 kg with ideal body weight within ±30%
Less than 100 mg/dl in fasting blood glucose and less than 140 mg/dl in an oral glucose tolerance test (OGTT)
Able to give informed consent
Exclusion Criteria:
Major medical illness such as cardiovascular, neurologic, psychiatric, renal, pulmonary and hepatic diseases
History of disease that could interfere with the test products or impede their absorption such as gastrointestinal disease or gastrointestinal surgery
Medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
Poor vital sign (systolic blood pressure: below 100 mmHg or above 150 mmHg, diastolic blood pressure: below 65 mmHg or above95 mmHg)
Allergic or hypersensitive to any of the ingredients in the test products; treated with any drug within past 2 weeks
Participation in any other clinical trials within past 2 months
Alcohol consumption above 21 units per week or abnormal screening laboratory test
Being judged by the responsible physician of the local study center as unfit to participate in the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Soo-Wan Chae, MD., PhD
Organizational Affiliation
Chonbuk National University Hospital
Official's Role
Study Director
Facility Information:
Facility Name
Clinical Trial Center for Functional Foods; Chonbuk National University Hospital
City
Jeonju
State/Province
Jeollabuk-do
ZIP/Postal Code
560-822
Country
Korea, Republic of
12. IPD Sharing Statement
Learn more about this trial
The Effects of Mixed Grain on Blood Glucose and Insulin in Healthy Male
We'll reach out to this number within 24 hrs